Listeria monocytogenes Meningitis After Treatment With Infliximab in an 8-Year-Old Pediatric Patient With Crohn's Disease

Uzma Rani; Ajay Rana

doi:10.14309/crj.0000000000000624

Listeria monocytogenes Meningitis After Treatment With Infliximab in an 8-Year-Old Pediatric Patient With Crohn's Disease

ACG Case Rep J. 2021 Jul 9;8(7):e00624. doi: 10.14309/crj.0000000000000624. eCollection 2021 Jul.

Authors

Uzma Rani¹, Ajay Rana²

Affiliations

¹ Department of Pediatrics, Golisano Children's Hospital, The State University of New York, Upstate Medical University, Syracuse, NY.
² Department of Gastroenterology, Hepatology, and Nutrition, The State University of New York, Upstate Medical University, Syracuse, NY.

Abstract

Anti-tumor necrosis factor-alpha agents are used for the treatment of inflammatory bowel disease. Central nervous system infections are rare adverse effects of these medications, and to the best of our knowledge, there are only 2 case reports from the pediatric patient population. We report a case of an 8-year-old patient with Crohn's disease who developed Listeria meningitis while on infliximab.

Publication types

Case Reports